1.68
price up icon0.00%   0.00
after-market Dopo l'orario di chiusura: 1.68
loading
Precedente Chiudi:
$1.68
Aprire:
$1.68
Volume 24 ore:
134.78K
Relative Volume:
0.47
Capitalizzazione di mercato:
$50.52M
Reddito:
$210.70K
Utile/perdita netta:
$-21.37M
Rapporto P/E:
-1.5273
EPS:
-1.1
Flusso di cassa netto:
$-21.10M
1 W Prestazione:
+4.35%
1M Prestazione:
-6.15%
6M Prestazione:
-23.64%
1 anno Prestazione:
+55.56%
Intervallo 1D:
Value
$1.66
$1.72
Intervallo di 1 settimana:
Value
$1.55
$1.90
Portata 52W:
Value
$0.89
$3.19

Gain Therapeutics Inc Stock (GANX) Company Profile

Name
Nome
Gain Therapeutics Inc
Name
Telefono
(301) 500-1556
Name
Indirizzo
4800 HAMPDEN LANE, BETHESDA
Name
Dipendente
25
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
GANX's Discussions on Twitter

Confronta GANX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GANX
Gain Therapeutics Inc
1.68 56.01M 210.70K -21.37M -21.10M -1.10
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-07 Iniziato Scotiabank Sector Outperform
2024-12-06 Iniziato ROTH MKM Buy
2024-08-14 Ripresa Oppenheimer Outperform
2021-04-12 Iniziato BTIG Research Buy
2021-04-12 Iniziato Oppenheimer Outperform

Gain Therapeutics Inc Borsa (GANX) Ultime notizie

pulisher
Jul 24, 2025

What makes Gain Therapeutics Inc. stock attractive to long term investorsFree Market Dynamics Reports - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference - The Manila Times

Jul 24, 2025
pulisher
Jul 24, 2025

Gain Therapeutics to Present at BTIG's Annual Biotechnology Conference. - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

Gain Therapeutics Leadership Team Set for Exclusive Fireside Chat at BTIG Annual Biotech Conference - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

Gain Therapeutics Inc. Stock Analysis and ForecastPhenomenal capital gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Indaptus Therapeutics Inc. a good long term investmentRapid market gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Gain Therapeutics Inc. a good long term investmentBreakout portfolio performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Gain Therapeutics Inc. stockMarket-leading growth rates - PrintWeekIndia

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Gain Therapeutics Inc. stock priceRemarkably fast returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

What drives Monte Rosa Therapeutics Inc. stock priceExplosive portfolio gains - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

Aardvark Therapeutics Inc. Stock Analysis and ForecastHigh-octane gains - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Allogene Therapeutics Inc. stock priceTremendous gains - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

Is Nurix Therapeutics Inc. a good long term investmentSkyrocketing investment returns - Jammu Links News

Jul 19, 2025
pulisher
Jul 19, 2025

Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX), Abbott Laboratories (ABT) and ANI Pharmaceuticals (ANIP) - The Globe and Mail

Jul 19, 2025
pulisher
Jul 19, 2025

Is Grace Therapeutics Inc. a good long term investmentTremendous gains - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Healthcare Stocks to Watch: Gain Therapeutics, Abbott Laboratories, and ANI Pharmaceuticals - AInvest

Jul 19, 2025
pulisher
Jul 18, 2025

Is vTv Therapeutics Inc. a good long term investmentTremendous gains - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Bicara Therapeutics Inc. Stock Analysis and ForecastHigh-velocity gains - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

What drives Mineralys Therapeutics Inc. stock priceHigh-octane gains - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Is Soleno Therapeutics Inc. a good long term investmentSuperior trading gains - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

What drives Avalo Therapeutics Inc. stock priceExceptional risk-adjusted gains - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Gain Therapeutics Inc. stock outlookLow Risk High Reward Picks - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Does Avalo Therapeutics Inc. stock pay reliable dividendsReal Time Alert Service - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is Heron Therapeutics Inc. stock a good hedge against inflationDaily Gain Forecast - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

What risks could impact LOGC stock performanceFree Expert-Led Investment Training - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Gain Therapeutics Announces $7 Million Public Offering - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Form 424B5 Gain Therapeutics, Inc. - StreetInsider

Jul 17, 2025
pulisher
Jul 17, 2025

How Nurix Therapeutics Inc. stock performs during market volatility200 Percent Gain Alert - Newser

Jul 17, 2025
pulisher
Jul 16, 2025

Why Gain Therapeutics Inc. stock attracts strong analyst attentionDaily Stock Radar - beatles.ru

Jul 16, 2025
pulisher
Jul 16, 2025

Neurodegenerative Biotech's Capital Crunch: The Dilution Dilemma in $7M Offerings - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Gain Therapeutics Announces Pricing of $7.0 Million Public Offering - The Manila Times

Jul 16, 2025
pulisher
Jul 16, 2025

Gain Therapeutics on pricing stock-and-warrants offering - TradingView

Jul 16, 2025
pulisher
Jul 16, 2025

Gain Therapeutics Secures $7M Funding to Advance Novel Parkinson's Treatment Pipeline - Stock Titan

Jul 16, 2025
pulisher
Jul 16, 2025

US Futures Trade Mixed As June Inflation Ticks Up: ASML, Morgan Stanley, Goldman Sachs, BofA Earnings In Focus - Benzinga

Jul 16, 2025
pulisher
Jul 16, 2025

Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket - Benzinga

Jul 16, 2025
pulisher
Jul 15, 2025

Gain Therapeutics' High-Stakes Gamble: Can GT-02287 Rewrite the Neurodegenerative Treatment Playbook? - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Gain Therapeutics Plans Public Offering of Common Shares, Warrants - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Gain Therapeutics falls on equity offering plans - TradingView

Jul 15, 2025
pulisher
Jul 15, 2025

Gain Therapeutics Announces Proposed Public Offering - The Manila Times

Jul 15, 2025
pulisher
Jul 15, 2025

Gain Therapeutics stock falls after announcing public offering By Investing.com - Investing.com Canada

Jul 15, 2025
pulisher
Jul 15, 2025

Gain Therapeutics stock falls after announcing public offering - Investing.com

Jul 15, 2025
pulisher
Jul 15, 2025

Gain Therapeutics, Inc. Proposes Underwritten Public Offering of Common Stock and Warrants - Nasdaq

Jul 15, 2025

Gain Therapeutics Inc Azioni (GANX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):